Abstract -Enterococci isolated from a total number of 68 dairy products and 28 human fecal samples were screened for bacteriocin production. The incidence of the bacteriocin-production trait was highest among the cream samples (33.51%), followed by dahi samples (15.55%), raw milk samples (9.51%), Cheddar cheese (9.2%) samples and human feces (4.72%). The isolates showed antilisterial effect besides activity against other lactic acid bacteria. Sixty potent bacteriocin-producing isolates of enterococci were evaluated for the incidence of virulence characters for their safe exploitation. None of the isolates was found to exhibit gelatinase, DNAse or β-hemolysis activity. Furthermore, only 4 bacteriocin-producing isolates among 60 were observed to be vancomycinresistant. It was concluded that bacteriocin-producing Enterococcus strains lacking hemolytic activity and not carrying vancomycin resistance genes may be safely exploited as starter cultures, co-cultures or probiotics.
INTRODUCTION
Studies on bacteriocins produced by lactic acid bacteria (LAB) have attracted increasing interest in recent years because of their potential use as biopreservatives in the food industry to eliminate spoilage and food-borne pathogenic bacteria [36] . These bacteriocins fulfill all the requirements of an ideal food preservative without showing any deleterious effect on the food. Furthermore, they are digested by human proteolytic enzymes in the gastrointestinal (GI) tract. Bacteriocins produced by LAB are ribosomally synthesized bactericidal peptides or proteins that are cationic, hydrophobic or amphiphilic molecules of 20 to 60 amino acid residues [33, 47] .
Enterococci are Gram-positive bacteria, which fit the general definition of LAB. They are often isolated from dairy systems as desirable microbiota and are believed to play an important role in cheese ripening due to their high lipolytic, proteolytic and flavor-producing activities [21, 28] . Investigations have resulted in the recognition that production of antilisterial bacteriocins is a common characteristic within this group of bacteria [3, 21, 37, 54] . Enterocins, the antibacterial peptides produced by Enterococcus species are small, hydrophobic and thermostable with activity over a wide range of pH. Enterocins are active against many Gram-positive bacteria encompassing undesirable and pathogenic microbes, such as Clostridia, Bacillus, Staphylococcus and Listeria, as well as some Gram-negative bacteria [22, 23, 43] . There are several reports regarding the application of bacteriocin-producing enterococci as starter or protective cultures or use of their bacteriocins for protection against spoilage and pathogenic bacteria in cheese [21, 28, 30, 50] . This fact stimulates the special interest in enterocins as potential food preservatives. Furthermore, enterococci are used as probiotics in some countries [31] . The strain Ent. faecium SF68 has been studied in detail as a probiotic in the treatment of antibioticassociated diarrhea [23, 40] .
Some potential drawbacks of the genus Enterococcus have often been the subject of controversy. In the recent reviews on the potential risks related to the use of enterococci in food technology it has been reported that some Ent. faecalis strains are associated with a number of human infections viz., endocarditis, urinary tract infections and bacteraemia, and a few Ent. faecium strains have also been implicated as the causative agent in enterococcal infections [8, 21, 25, 53] . Furthermore, in recent years, there has been an emergence of antibiotic-resistant enterococci (ARE), Ent. faecium being the predominant enterococcal species in the subset of vancomycin-resistant (VRE) isolates [45] . However, there exists strong phenotypic variability within the genus Enterococcus and some significant properties, such as antibiotic resistance and potential pathogenicity, have been reported to be dependent on the source of the isolate [23, 25, 38] .
Since bacteriocin producers are being exploited in the food industry for the purpose of biopreservation in place of chemical preservatives, the safety of such strains is of major concern. The present investigation was carried out to study the frequency of enterococci and bacteriocin producing enterococci in dairy products. Furthermore, a study regarding the incidence of virulent characters in the bacteriocinogenic enterococci was also carried out to investigate the safety of such strains for their safe application in food products.
MATERIALS AND METHODS

Bacterial strains
A total number of 68 samples of dairy products comprising raw milk (42) , raw cream (13) , dahi (7) and Cheddar cheese (6) was obtained from various sources such as the local market and the Dairy of the National Institute for the isolation of enterococci. Enterococci were also isolated from 28 human fecal samples. Decimal dilutions of the samples were plated on Citrate Azide Agar (CAA) [51] and incubated at 37
• C for 3 days. A total number of 1061 isolates was randomly selected. After microscopic examination, the enterococcal isolates, sub-cultured to purity on MRS medium [13] , were tested for Gram stain and catalase reaction. Isolated colonies were characterized to genus level by physiological, biochemical and morphological tests according to the criteria suggested by Facklam and Collins [19] and Devriese et al. [16] . They were then frozen at -80
• C in MRS broth containing 50% glycerol.
Bacterial cultures, media and culture conditions
Strains Lactobacilli, pediococci and enterococci were propagated in MRS broth [13] ; L. lactis, Strep. thermophilus and M. luteus in M17 broth [57] and E. coli, List. monocytogenes, Staph. aureus, Sh. dysenteriae, Ps. aeruginosa and Salm. typhi were propagated in Brain Heart Infusion (BHI) broth. The incubation temperature for the growth of these cultures was 37
• C, except for lactococcal strains (30 • C).
Screening for bacteriocinproducing strains
All the presumptive enterococcal isolates (1061) were tested for bacteriocin production. Enterococcal isolates were propagated twice in MRS broth. Cellfree culture supernatants (CFCS) of these were prepared according to the method of Cintas et al. [11] . CFCS were obtained from enterococcal strains grown in MRS broth at 37
• C until the early stationary phase (O.D. 620 = 1.2). After centrifugation (30 min at 12 000× g and 4
• C), the pH of the supernatant was adjusted to 6.0 and the supernatant was heat-treated at 90
• C for 10 min to kill live cells. The antimicrobial activity of the CFCS was determined by spot-on lawn assay [60] with slight modifications. Five microliters of the cell-free supernatants were spotted on TGE agar (1% Tryptone, 2% Glucose, 1% Yeast Extract, 1.5% Agar; [7] plates overlaid with 5 mL of the TGE soft agar (0.75% agar) seeded with indicator strains (10 5 cfu·mL −1 )). The plates were kept undisturbed for 2 h and subsequently incubated at 37
• C. After 24 h, the diameters (mm) of the growth inhibition zones were measured. The isolates that did not form any zone were discarded. Enterococcal strains that formed zones against any of the three indicators (Ped. acidilactici LB 42, Ent. faecalis DSM 20478 and E. coli NCDC 134) were considered positive and their antibacterial spectra were determined against a number of both Gram-positive and Gram-negative organisms (Tab. II).
Sensitivity to enzymes
CFCS were incubated for 2 h at 37
• C with the following enzymes (Sigma Chemical Company, St. Louis, USA.): trypsin, pronase E, α-chymotrypsin, lipase, proteinase K, protease I, protease VIII, papain and catalase to a final enzyme concentration of 1 mg·mL −1 . Catalase treatment was performed to avoid possible inhibition by hydrogen peroxide. All the enzymes were dissolved in sterile 50 mmol·L −1 phosphate buffer (pH 7.0) at a concentration of 10 mg·mL −1 . Controls consisted of samples of enzymes in sterile medium and untreated crude extract. Residual enterocin activity was detected by the spot-on lawn assay as described above, against the indicator strain of Ped. acidilactici LB 42.
Antibiotic susceptibility test
Susceptibility of 60 potent bacteriocinproducing Enterococcus strains to the different antibiotics was tested using a Disc Diffusion Assay on Mueller Hinton Agar No. 2 according to the National Committee for Clinical Laboratory Standards [46] , using the following antimicrobials (Himedia Laboratories, Pvt. Ltd., Mumbai, India): 
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Detection of virulence determinants
Hemolysis
The Enterococcus strains were grown overnight in MRS medium at 37
• C, and then transferred onto Blood Agar Base (HiMedia Laboratories, Pvt. Ltd., Mumbai, India) plates containing 5% of fresh calf blood. The plates were incubated for 3 d at 37
• C. The hemolytic reaction was recorded as β-hemolysis if a clear zone of hydrolysis of red blood cells was formed around the colonies, as α-hemolysis, if a green zone appeared around the colonies or as γ-hemolysis if no clear or no green zone of hemolysis appeared around colonies.
DNAse test
All the bacteriocinogenic enterococcal strains were streaked on DNAse agar medium (HiMedia Laboratories, Pvt. Ltd., Mumbai, India) to check their production of DNAse enzyme. Plates were incubated at 37
• C for 48 h. A clear, pinkish zone around the colonies after incubation was considered positive for DNAse production.
Liquefaction of gelatin
Gelatinase production by selected bacteriocinogenic enterococcal isolates was studied by using TND agar (1.7% tryptone, 0.3% neopeptone, 0.25% dextrose, 0.5% NaCl, 0.25% K 2 HPO 4 and 1.5% agar) containing 0.4% gelatin. Petri dishes containing the medium were spot-inoculated with the test culture and incubated at 37
• C for 3 d. The Petri dishes were then flooded with saturated ammonium sulfate solution. Development of clear zones around the inoculated spot against the opaque background indicates a positive reaction.
RESULTS
Enterococci were detected in all the samples of raw milk, raw cream, dahi and Cheddar cheese, and also in human feces. Enterococcal counts varied from 10 2 -10 3 cfu·mL −1 (or g −1 ) in raw milk, Cheddar cheese and dahi and 10 4 -10 6 cfu·mL −1 in raw cream. In human feces, these counts varied from 10 5 to 10 7 cfu·g −1 . One thousand and sixtyone enterococcal isolates were randomly selected and screened for the bacteriocinproduction characteristic. Out of these, 135 (12.72%) isolates formed zones against at least one of the indicator strains tested. However, among the bac + isolates, 92.59% of the isolates showed antibacterial (or antimicrobial) activity against Ped. acidilactici LB 42, whereas only 45.18% of the isolates were effective against Ent. faecalis DSM 20478; but none of the 135 isolates tested was able to inhibit E. coli 134. The incidence of the bacteriocin-production characteristic was highest among the cream samples (33.51%), followed by dahi samples (15.55%), raw milk samples (9.51%), Cheddar cheese samples (9.2%) and human feces (4.72%) (Fig. 1) .
Out of 135 bacteriocin-producing enterococcal strains, 60 (44%) were found to CFCS were found to be sensitive to trypsin, pronase E, α-chymotrypsin, proteinase K, protease I, protease VIII and papain, but were insensitive to lipase and catalase, showing the protein nature of the inhibitory principle.
None of the 60 bacteriocin-producing enterococcal strains were found to be positive for gelatin liquefaction and DNAse production. However, 9 bacteriocinogenic enterococcal isolates of different origins viz. KH RH 29
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KH 62, KH 70, RH 78 and FH 90 showed weak α-hemolysis, while no hemolytic activity was observed for the rest of the strains tested. Furthermore, incidence of α-hemolysis was not found to be sourcedependent.
Antibiograms of sixty bacteriocinogenic enterococcal strains were determined by using a Disc Diffusion Assay. All the sixty strains of enterococci possessing the bacteriocin-production characteristic were sensitive to ofloxacin and 93.33% of the strains were sensitive to vancomycin. Only 6.67% of the isolates were resistant to chloramphenicol and 10% of the isolates were resistant to tetracycline, co-trimoxazole and ampicillin. Resistance of bacteriocinogenic enterococci was observed for cephalothin and cefuroxime (88.33%), followed by their resistance to amikacin (70%), erythromycin (46.67%), clindamycin (33.33%), penicillin G (25%) and gentamicin (23.33%). Out of a total of four vancomycin-resistant strains, two strains were from raw milk and the other two were from cream samples. Nine moderately resistant enterococcal isolates were from cream samples and one was from a dahi sample. However, none of the isolates from human feces was found to be resistant to vancomycin (Fig. 2) .
DISCUSSION
Enterococci form part of LAB, that are of great importance in foods. These organisms have been implicated in spoilage of processed meats; however, they are important in ripening and aroma development of certain traditional cheeses and sausages and are intentionally used as starter cultures or as culture adjuncts for the manufacture of certain types of cheeses [21, 23, 28, 48, 55] . Levels of enterococci in different cheese curds have been reported to range from 10 4 to 10 6 cfu·g −1 and in fully ripened cheeses from 10 5 to 10 7 cfu·g −1 [25, 27, 39] . In humans, enterococci, along with approximately 450 other aerobic and anaerobic bacterial species, form a part of the normal intestinal flora. In most individuals, 10 5 -10 7 cfu of enterococci per gram in stools have been reported [44] .
Enterococci have drawn research interest because of their presence almost everywhere in the food chain, as well as in the Gelatin Hemolysin DNase production production production 1.
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environment, and also because of their use in the production of probiotics and other fermented foods. Besides this, bacteriocin production is also a common characteristic among enterococci and is responsible for the inhibition of food spoilage and pathogenic organisms [4, 14, 25, 30, 35] . Enterococci are, therefore, interesting as protective cultures for cheese manufacture and also for the preparation of novel probiotics [17, 21, 49] . However, severe safety criteria must be established to guarantee a safe, commercial use of enterococci. Considering their clinical involvement in infections and antibiotic resistance [2, 42] , the safety of Ent. faecium and Ent. faecalis strains associated with food fermentation and probiotics is being questioned. Therefore, it becomes imperative to evaluate the bacteriocin-producing enterococcal strains for their virulence determinants and vancomycin resistance. Bacteriocin production was observed mainly among the strains of Ent. faecalis and Ent. faecium, along with some other species of enterococci. These species encompassed strains of different origins covering dairy food isolates (60 strains from raw milk, 41 from cream, 14 from dahi and 6 from Cheddar cheese) and human feces (14 isolates). These findings are further corroborated by other studies showing that bacteriocin-producing enterococci can exist in diverse environments and are also found associated with the gastrointestinal tract of humans [15, 27, 41] . Among Enterococcus strains of human origin, Ent. faecium (16.67%) displayed the highest bacteriocinogenic activity. Reports showing isolation of bacteriocinogenic enterococci from a number of different sources e.g. meat products, black olives, infant stools, soy beans, goat's cheese, yellow cheese from sheep's milk, fermented products from mare's milk and corn silage [1, 3, 5, 20, 22, 35, 37, 49, 54] confirm their ubiquitous occurrence and persistence. Enterococcal strains were found to exhibit a wide range of activity against Gram-positive organisms but no correlation could be established between the source of isolation of the strains and the inhibitory spectrum. Importantly, enterocins show a strong activity against Listeria, which can be of practical use in the food industry [18, 26, 35] . Enterococcus strains displaying an inhibitory spectrum due to the production of enterocins targeted against Listeria and/or Clostridium [30, 59] have been reported to be interesting as protective cultures for cheese manufacture [48] . While a few reports have shown enterocins to be active against Gram-negative bacteria such as E. coli [5, 26, 49, 58] , Shigella sonnei, Shigella flexeneri [54] and Vibrio cholera [52] , the majority of the reports show that bacteriocins are least active towards Gram-negative organisms [3, 6, 12, 37] . In the present study none of the enterocins was found to be effective against Gram-negative organisms.
It is imperative that the Enterococcus strains, in particular those showing a broad spectrum of activity and having potential application in foods, be checked for the presence of virulence characteristics. Accordingly, sixty bacteriocinogenic Enterococcus strains exhibiting broad spectrum activity were evaluated carefully for the presence of hemolysins, gelatinase and DNAse production. Cytolysin/hemolysin activity is seen as a potent virulence factor in several animal model studies [32, 34] . No β-hemolysis was observed in Ent. faecium or in Ent. faecalis strains of dairy or fecal origin, thus apparently showing the absence of the cytolysin gene in the bacteriocin-producing Ent. faecalis and Ent. faecium strains. Alpha-hemolysis among enterococcal strains may usually be confronted, but it does not pose a serious threat as other virulence characteristics do. Absence of hemolytic activity should be a selection criterion for (bacteriocin-producing) starter strains of dairy use [28, 30] . Nevertheless, absence of hemolytic activity in enterococci isolated from food does not mean that these bacteria are non-virulent [23, 24] ; a thorough understanding of all the characteristics will certainly contribute to the safety evaluation of enterococci. Besides testing for hemolysin production, the isolated bacteriocinogenic strains of enterococci were tested for gelatinase production and DNAse production, that may have a role in virulence [53, 56] . However, none of the strains either of food or human origin was found to possess any of these virulence traits. Such strains may not, therefore, pose any problem for their use in foods, as also reported by other authors [9, 21, 25, 38] .
The incidence of antibiotic-resistant enterococci (ARE) is quite widespread in foods. They have been isolated from meat products, dairy products and ready-toeat foods, and even within enterococcal strains used as probiotics [24, 27] . The role of ARE, especially VRE (vancomycinresistant enterococci), has been emphasized by Giraffa [27] , as possible natural food reservoirs in the dissemination of antibiotic resistance in the environment. For safety reasons, sensitivity of commercially exploitable strains against commonly used antibiotics is desirable in order to be used as co-cultures or starter cultures. Examples of acquired resistance through exchange of resistance-encoding genes are resistance to tetracycline, chloramphenicol, glycopeptides and vancomycin. In this study, the majority of strains were found to be sensitive to these antibiotics. Giraffa and Sisto [29] did not find VRE among the strains isolated from Italian cheeses. In contrast, high frequencies of ARE and VRE have been reported among isolates from meat [38] .
In conclusion, enterococci are ubiquitous in nature and are present in dairy products and the gut of humans. Their capacity to produce bacteriocins active against spoilage or pathogenic bacteria, particularly against Listeria, might be a powerful tool for the protection of certain dairy products and meat products against such pathogens. However, some enterococci carry virulence factors, but incidence of these factors in the enterococcal isolates of food or human origin is almost negligible. Antibiotic-resistant strains of enterococci that are also bacteriocin producers may be encountered in some dairy foods and the human intestine but their frequency of incidence is much less. Nevertheless, a careful evaluation of the commercially exploitable strains may be very helpful for the food industry for their safe use.
